Join to View Full Profile
1515 Holcombe Blvd, Unit 85Department of Pathology, AnatomicalHouston, TX 77030
Phone+1 832-794-5633
Dr. Hosseini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. S. Hosseini is a pathologist in Houston, TX affiliated with the University of Texas M.D. Anderson Cancer Center. Dr. Hosseini specializes in cytopathology and anatomic pathology and is experienced in molecular genetic pathology, fine needle aspiration, cytopathology, and head and neck pathology. Dr. Hosseini has more than 30 publications and over 3300 citations.
Education & Training
University of California (San Francisco)Fellowship, Cytopathology, 2020 - 2021
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2017 - 2020
University of TorontoPhD, Human Genetics and Genomics, 2014- University of TorontoMSc, Human Genetics, 2006
Isfahan University of Medical SciencesClass of 2001
Certifications & Licensure
TX State Medical License Active through 2026
CA State Medical License 2019 - 2025
American Board of Pathology Anatomic Pathology- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
Royal College of Physicians and Surgeons of CanadaSpecialist in Anatomical Pathology
Publications & Presentations
PubMed
- Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy.Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, Naifa L Busaidy, Priyanka Iyer
JCO Precision Oncology. 2025-01-01 - [18F]-Fluorodeoxyglucose Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma Following BRAF-Targeted Therapy.Samir A Dagher, Kim O Learned, Richard Dagher, Jennifer Rui Wang, Xiao Zhao
AJNR. American Journal of Neuroradiology. 2024-11-21 - 6 citationsInitial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.Sarah Hamidi, Ramona Dadu, Mark E Zafereo, Renata Ferrarotto, Jennifer R Wang
JAMA Oncology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
